All Reports
GEHC·HealthcareBUY
GE HealthCare Technologies Inc.
Benjamin Evensen·November 14, 2026
Price Target
$97.76
Upside
+17.8%
Investment Thesis
We initiate GE HealthCare with a BUY and a blended target of USD 97.76, about 17.8% upside. The stock trades at 15.1x our FY2027E adjusted EPS versus a peer median of 16.8x, and at 12.7x trailing EBITDA versus 14.4x. Shares fell 13% in April on a guidance cut but have recovered roughly 40% on strong Q2 and Q3 results. Even so, the market has not fully priced in easing cost pressures and growth in the higher-margin PDx business.
Full Report
The complete report includes a DCF valuation, comparable company analysis, and full investment thesis with risk factors.
Report Details
AnalystBenjamin Evensen
PublishedNovember 14, 2026
SectorHealthcare
RatingBUY
Price Target$97.76
Current Price$83.02
For educational purposes only. Not investment advice. Price targets reflect analyst estimates as of the publication date.